Lihui Xu

1.1k citations
18 papers · 783 indexed · h-index 9
Topics
Monoclonal and Polyclonal Antibodies Research (13 papers)Glycosylation and Glycoproteins Research (8 papers)HER2/EGFR in Cancer Research (4 papers)

In The Last Decade

Lihui Xu

18 papers receiving 753 citations

Peers

Lihui Xu
Comparison fields: 5 of 66
  • Molecular Biology 564
  • Radiology, Nuclear Medicine and Imaging 444
  • Oncology 248
  • Immunology 145
  • Computational Theory and Mathematics 56
Replace Deborah Wilsker with:
Deborah Wilsker United States
Nicolas Béry France
Erika Kovács Hungary
Alicia M. Chenoweth United Kingdom
Peter A. Hoyne Australia
Matthew Onsum United States
Andrew Buchanan United Kingdom
William van Osdol United States
Ami Miller United Kingdom
Stefan Ewert Switzerland
Lihui Xu relative to Deborah Wilsker United States Deborah Wilsker's profile →
Citations per field
00.5×1.5×
Deborah Wilsker · 1×
Citations per year

Countries citing papers authored by Lihui Xu

Since Specialization
Citations

This map shows the geographic impact of Lihui Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihui Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihui Xu more than expected).

Fields of papers citing papers by Lihui Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lihui Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihui Xu. The network helps show where Lihui Xu may publish in the future.

Co-authorship network of co-authors of Lihui Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lihui Xu. A scholar is included among the top collaborators of Lihui Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lihui Xu. Lihui Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 8
2 1
3 2
4 24
5 2
6 1
7 56
8 27
9 87
10 21
11 1
12 3
13 1
14 2
15 275
16 5
17 176
18 91

About Lihui Xu

Lihui Xu is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Sensory Systems, having authored 18 papers that have together received 783 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (13 papers), Glycosylation and Glycoproteins Research (8 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (444 citations), Oncology (248 citations) and Molecular Biology (564 citations). Lihui Xu has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Neeraj Kohli, Ulrik B. Nielsen, Aaron K. Sato, Jonathan B. Fitzgerald, Birgit Schoeberl, Lawrence J. Stern, Alexey A. Lugovskoy, Brian D. Harms, Emily A. Pace and Michael J. Feldhaus. Their work appears in journals such as Cancer Research, Theranostics and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026